The U.S. Food and Drug Administration (FDA) has published a final rule on “Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations,” which permits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback